It is with great interest that we read a number the article by Saariniemi et al. entitled
“The cost utility of reduction mammaplasty at medium-term follow-up: A prospective
study” published in the January issue of the Journal.
1
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Plastic, Reconstructive & Aesthetic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The cost utility of reduction mammaplasty at medium-term follow-up: a prospective study.J Plast Reconstr Aesthet Surg. 2012 Jan; 65 (Epub 2011 Aug 27): 17-21
- Unsuspected breast carcinoma in reduction mammaplasty specimens and the role of pathologic examination.Plast Reconstr Surg. 2011 Sep; 128 (author reply 817–18): 815-816
Article info
Publication history
Published online: March 29, 2012
Identification
Copyright
© 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Reply to the cost-utility of reduction mammaplasty, at medium-term follow-up : A prospective studyJournal of Plastic, Reconstructive & Aesthetic SurgeryVol. 65Issue 9
- PreviewI want to thank Drs. Marino et al. for their interest and kind words. As they emphasize, the oncological aspect of reduction mammaplasty (RM) is an important consideration. In breast hypertrophy, by reducing the amount of normal breast tissue or breast tissue with increased risk of developing breast cancer, the subsequent risk for breast cancer is diminished, although other unknown factors contribute.1 Combined preoperative screening and histological examination of the specimen is supported to detect occult breast carcinoma in RM patient populations.
- Full-Text
- Preview
